Inhibrx, Inc. (NASDAQ:INBX – Get Free Report) shares dropped 2.5% during trading on Friday . The company traded as low as $33.95 and last traded at $34.06. Approximately 25,427 shares traded hands during trading, a decline of 94% from the average daily volume of 407,643 shares. The stock had previously closed at $34.94. Analyst Ratings […]
Inhibrx, Inc. (NASDAQ:INBX – Get Free Report)’s stock price hit a new 52-week high on Thursday . The stock traded as high as $30.54 and last traded at $29.57, with a volume of 17510 shares changing hands. The stock had previously closed at $29.04. Analyst Upgrades and Downgrades Separately, JMP Securities restated a “market outperform” […]
Inhibrx (NASDAQ:INBX – Get Free Report) and Halozyme Therapeutics (NASDAQ:HALO – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, profitability and risk. Profitability This table compares Inhibrx and Halozyme Therapeutics’ net […]
Inhibrx, Inc. (NASDAQ:INBX – Get Free Report) was the target of a significant decrease in short interest in the month of August. As of August 31st, there was short interest totalling 5,090,000 shares, a decrease of 12.8% from the August 15th total of 5,840,000 shares. Based on an average daily trading volume, of 398,300 shares, […]
Inhibrx (NASDAQ:INBX) Trading Up 4 3% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.